Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion type Assertion NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_head.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion description "[The critical endpoint of the study was the influence of key baseline characteristics (CD4 cell counts, clinical stage, HIV-1 p24 antigen, virus phenotype and viraemia) upon the time to development of mutation at codon 215.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_provenance.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion evidence source_evidence_literature NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_provenance.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion SIO_000772 11322281 NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_provenance.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion wasDerivedFrom befree-20140225 NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_provenance.
- NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_assertion wasGeneratedBy ECO_0000203 NP829184.RAAQLg8OIml16M_P2bB7AXBLcsGauC9UjQjWyztoskeFk130_provenance.